The CMD Challenge Call funds established academic leaders developing transformative therapeutic solutions for cardiometabolic diseases. It targets projects addressing treatment optimization and organ damage reversal, offering up to EUR 2.1 million, bespoke incubation support for up to 3 years, infrastructure access, and expert networks to mature academic research into spin-out companies.
Open to established academic group leaders worldwide, excluding institutions in the UK, Germany, and Italy. Applicants should have an entrepreneurial mindset and focus on innovative therapeutic solutions.
